share

Pa (224–233), Influenza CAS NO 271573-27-4


Unit Price:

CAS No.:271573-27-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Pa (224–233), Influenza is a high-purity peptide sequence derived from the influenza virus, with the CAS registry number 271573-27-4. This compound is a critical research tool for virology and immunology studies, enabling the investigation of viral protein function and host immune response. It is essential for pharmaceutical R&D teams, academic researchers, and diagnostic developers focused on antiviral drug discovery, vaccine development, and advanced immunological assays.

Application

  • Antiviral Drug Discovery & Screening: Used as a target or reference standard in high-throughput screening assays to identify and validate novel influenza inhibitors.
  • Vaccine Research & Development: Serves as a key antigenic component for studying immune epitopes and evaluating vaccine candidate efficacy.
  • Immunological & Diagnostic Assays: Employed in ELISA, Western Blot, and other immunoassays for antibody detection, specificity testing, and diagnostic kit development.
  • Structural Biology Studies: Utilized in X-ray crystallography, NMR, and other techniques to elucidate the three-dimensional structure and interaction mechanisms of viral proteins.
  • Cell Signaling & Pathogenesis Research: Applied in cellular models to study the role of specific viral peptides in infection cycles and host cell response pathways.
  • Bioconjugation & Probe Development: Acts as a substrate for labeling with fluorophores or other tags to create tools for live-cell imaging and tracking studies.

Basic Information

Product Name Pa (224–233), Influenza
CAS No. 271573-27-4
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms Influenza A virus PA protein (224-233); PA (224-233) peptide; Influenza polymerase acidic protein peptide fragment 224-233; PA224-233; CAS 271573-27-4
EINECS Contact for details

Quality Control

Our Pa (224–233), Influenza is manufactured under strict quality systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and MS for identity confirmation, to ensure it meets the exacting standards required for research and development. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry environment. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a desiccator before opening to minimize moisture uptake.

Specification

Item Specification
Appearance White to off-white lyophilized powder
Identification (HPLC & MS) Conforms to reference standard
Purity (HPLC) ≥ 95%
Peptide Content ≥ 80%
Single Impurity (HPLC) ≤ 1.0%
Water Content (KF) ≤ 5.0%
Acetate Content (HPLC) ≤ 10.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.